期刊文献+

阿维A联合中药复方治疗皮肤科疾病,银屑病临床体会 被引量:5

Avi A combined traditional Chinese medicine treatment of skin diseases,psoriasis clinical experience
下载PDF
导出
摘要 目的探究银屑病患者采用阿维A联合中药复方治疗的方法和效果。方法选取2013年2月—2014年4月收治的82例银屑病患者进行治疗,随机分组,实验组49例患者采用阿维A联合中药的复合治疗,对照组33例患者仅采用阿维A胶囊的使用,对比患者治疗效果的差异和不良反应。结果实验组治疗的有效率为93.18%,没有不良症状的出现,对照组治疗有效率为75.76%,不良症状发生率为78.8%,差异显著,有统计学意义(P<0.05)。结论银屑病患者采用阿维A联合中药给予复方治疗,效果显著,使患者的身体症状得到明显改善,且很少出现不良反应,是一种值得广泛使用的药物。 Objective To explore psoriasis patients with Avi A combined traditional Chinese medicine treatment methods and ef-fects. Methods February 2013 April 2014 treated 82 cases of psoriasis treatment, randomized, 49 patients in the experimental group using composite Avi A joint Chinese medicine treatment, 33 patients in the control group using only Avi a capsule of use, differences between patients and adverse effects. Results The experimental group was 93.18% effective treatment, no adverse symptoms, treatment is effective in the control group was 75.76%, 78.8%incidence of adverse symptoms, significant difference was statistically significant (P〈0.05). Conclusion A joint psoriasis patients with Avi medicine given compound treatment, the effect is significant, so that the patient's physical symptoms significantly improved, and the rare adverse reactions, is a worthy drug widely used.
作者 曲胜 林爱凤
出处 《中国卫生产业》 2014年第27期5-6,共2页 China Health Industry
关键词 银屑病 阿维A联合中药复方治疗 治疗效果 Psoriasis Avi A combined traditional Chinese medicine treatment Treatment
  • 相关文献

参考文献2

二级参考文献18

  • 1李常兴,张锡宝,吴志华.甲氨蝶呤与银屑病[J].岭南皮肤性病科杂志,2004,11(2):200-203. 被引量:39
  • 2何玉清,张锡宝,费实,刘玉梅,吴志华.银屑病患者外周血Th1细胞分化偏态性分析[J].岭南皮肤性病科杂志,2002,9(1):1-4. 被引量:12
  • 3张锡宝,罗权,吴志华,陈绍谦.血管内皮生长因子及其受体在银屑病发病中的作用及意义[J].中华皮肤科杂志,2005,38(3):140-142. 被引量:30
  • 4景海霞,盛晚香.当归多糖对豚鼠银屑病样皮损中角质形成细胞凋亡的影响[J].武汉大学学报(医学版),2006,27(3):377-380. 被引量:11
  • 5Friedrich M, Krammig S, Henze M, et al. Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype[J]. Arch Dermatol Res. 2000_ 292 ( 10 ): 519 - 521.
  • 6Jeffes EW, McCullough JL, Pittelkow MR, et al. Methotrexate therapy of psoriasis:differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate [ J ]. J Invest Dermatol,1995,104(2) :183 - 188.
  • 7Piskin G,Sylva-Steenland RM,Bos JD,et al.T cells in psoriatic lesional skin that survive conventional therapy with NB—UVB radiation display reduced IFN—gamma expression[J].Arch Dermatol Res,2004,295(12):509—516.
  • 8Piskin G,Heydendael VM,de Rie MA,甜a1.Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN—gamma and IL-4 expression in psoriatic skin in situ[J].Arch Dermatol Res,2003,294(12):559—562.
  • 9Servitje O,Bordas X,Seron D,et al.Changes in T-cell phenotype and adhesion molecules expression in psoriatic lesions after low-dose cyclosporin therapy[J].J Cutan Pathol,1996,23(5):431—436.
  • 10Kawahira K. Immunohistochemical Staining of Proliferating cell nuclear antigen(PCNA) in malignant and nonmalignant skin diseases [ J ]. Arch Dermatol Res,1999,291 (7 -8) :413 -418.

共引文献23

同被引文献43

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部